This trial will compare the outcomes of patients who receive BMAC after meniscectomy to those who don't, in terms of symptoms, physical examination, MRI, radiographs, and synovial fluid analysis. The hypothesis is that BMAC will improve outcomes.
1 Primary · 3 Secondary · Reporting Duration: One Year
100 Total Participants · 2 Treatment Groups
Primary Treatment: Bone Marrow Aspirate Concentrate · Has Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: